{"nct_id":"NCT00401843","title":"A Study of the Safety and Efficacy of CNTO 328 and Bortezomib to Bortezomib Alone in Patients With Relapsed or Refractory Multiple Myeloma","status":"COMPLETED","status_verified_date":"2019-11","start_date":"2006-11-28","start_date_type":"ACTUAL","primary_completion_date":"2011-08-16","primary_completion_date_type":"ACTUAL","completion_date":"2019-09-24","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JNJ"]}